Online citations, reference lists, and bibliographies.

Immunity Against Chlamydia Trachomatis

E. Marks, N. Lycke
Published 2008 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Chlamydia trachomatis, the etiology of one of the most common human infections, is responsible for an increasing number of genital tract infections world-wide. In addition, this obligate intracellular pathogen infects epithelial cells of the eye, resulting in trachoma and, as a sequela, blindness. The genital tract infection often leads to severe damage of the reproductive tract, resulting in tubal factor infertility. Infection of the genital tract stimulates a complex array of host immune responses involving innate as well as adaptive immune responses. Cells of the innate immune system recognize and limit the spread of infection, and influence the outcome of infection through the modulation of the adaptive immune response. Protective immunity against C. trachomatis involves primarily Th1 CD4+ T cells and IFN-γ production, while antibodies, and possibly CD8+ T cells, can contribute to protection. However, the immune response to infection is complex and those components that convey protective immunity may contribute to the pathogenesis. Therefore, it is believed that a balance between Th1/Th2 effector and regulatory T cell populations is required to avoid harmful immunopathology and permanent sequelae. Advances in our understanding of the immunobiology of the genital tract and better knowledge about chlamydial infections are key issues for the development of effective vaccines. In this context, identifying protective chlamydial antigens is crucial as well as investigating optimal immunization routes and vaccine formulations, including choice of adjuvant, will probably be central to an effective anti-chlamydial vaccine. In the present chapter, we discuss the current knowledge of correlates of protection and vaccine strategies.
This paper references
10.1016/S0264-410X(02)00680-1
Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge.
S. Pal (2003)
Adjuvanticity of the cholera toxin A1-based gene fusion protein, CTA1-DD, is critically dependent on the ADP-ribosyltransferase and Ig-binding activity.
L. Ågren (1999)
Suppressor T cells for IgE and IgG in Peyer's patches of mice made tolerant by the oral administration of ovalbumin.
J. Ngan (1978)
10.1128/iai.64.12.4976-4983.1996
Initial route of antigen administration alters the T-cell cytokine profile produced in response to the mouse pneumonitis biovar of Chlamydia trachomatis following genital infection.
K. Kelly (1996)
10.1128/IAI.74.1.225-238.2006
Comparison of Gamma Interferon-Mediated Antichlamydial Defense Mechanisms in Human and Mouse Cells
C. Roshick (2006)
10.1002/eji.1830230529
An intermolecular mechanism of T cell help for the production of antibodies to the bacterial pathogen, Chlamydia trachomatis.
J. E. Allen (1993)
10.1046/j.1440-1711.1998.00750.x
A novel concept in mucosal adjuvanticity: The CTA1‐DD adjuvant is a B cell‐targeted fusion protein that incorporates the enzymatically active cholera toxin A1 subunit
L. Ågren (1998)
10.1111/j.1462-5822.2006.00686.x
Stimulation of the cytosolic receptor for peptidoglycan, Nod1, by infection with Chlamydia trachomatis or Chlamydia muridarum
Lynn Welter-Stahl (2006)
10.1080/ejc.6.2.102.107
Chlamydia trachomatis and male infertility in Tunisia
R. Gdoura (2001)
10.1128/IAI.70.3.1538-1546.2002
Chemokine Expression Patterns Differ within Anatomically Distinct Regions of the Genital Tract during Chlamydia trachomatis Infection
H. Maxion (2002)
10.1046/J.1365-3156.1999.00479.X
Impairment of natural killer cell activity in Chlamydia trachomatis infected individuals.
E. Mavoungou (1999)
10.1111/j.1600-065X.2006.00431.x
Immune privilege in the gut: the establishment and maintenance of non‐responsiveness to dietary antigens and commensal flora
Onyinye I. Iweala (2006)
10.1111/j.1471-0528.1987.tb03125.x
Microbiological and histopathological findings in acute pelvic inflammatory disease
J. Paavonen (1987)
10.1128/IAI.69.12.7374-7379.2001
Role for Inducible Nitric Oxide Synthase in Protection from Chronic Chlamydia trachomatis Urogenital Disease in Mice and Its Regulation by Oxygen Free Radicals
K. Ramsey (2001)
10.1056/nejm199401133300207
Pelvic inflammatory disease.
W. McCormack (1994)
10.1046/j.1365-2567.2001.01199.x
CD8+ T cells in human uterine endometrial lymphoid aggregates: evidence for accumulation of cells by trafficking
G. R. Yeaman (2001)
The molecular mechanism of T-cell control of Chlamydia in mice: role of nitric oxide.
J. Igietseme (1996)
Critical role of CD28 in protective immunity against Salmonella typhimurium.
H. Mittrücker (1999)
10.1099/JMM.0.04836-0
Chlamydia trachomatis-induced death of human spermatozoa is caused primarily by lipopolysaccharide.
S. Hosseinzadeh (2003)
10.1111/j.1439-0272.2003.tb00864.x
Acrosome reaction in Chlamydia‐positive and negative patients
A. Jungwirth (2003)
10.1128/IAI.66.7.3390-3396.1998
Differential Kinetics and Distribution of Antibodies in Serum and Nasal and Vaginal Secretions after Nasal and Oral Vaccination of Humans
A. Rudin (1998)
10.1186/1471-2334-5-114
The CD14 functional gene polymorphism -260 C>T is not involved in either the susceptibility to Chlamydia trachomatis infection or the development of tubal pathology
S. Ouburg (2005)
10.1189/JLB.69.5.713
CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus.
M. Exley (2001)
10.1073/pnas.92.5.1644
Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants.
G. Douce (1995)
10.1111/j.1365-2958.1989.tb00176.x
The major outer membrane protein of Chlamydia trachomatis: critical binding site and conformation determine the specificity of antibody binding to viable chlamydiae.
J. Conlan (1989)
10.1095/biolreprod52.4.798
Expression of mitochondrial heat shock protein 60 in distinct cell types and defined stages of rat seminiferous epithelium.
A. Meinhardt (1995)
10.1111/J.1574-695X.2000.TB01449.X
Induction of mucosal immune responses in the human genital tract.
J. Mestecky (2000)
10.1038/356607a0
CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones
F. Harding (1992)
10.1128/IAI.70.3.1097-1105.2002
Dendritic Cells Pulsed with a Recombinant Chlamydial Major Outer Membrane Protein Antigen Elicit a CD4+ Type 2 Rather than Type 1 Immune Response That Is Not Protective
J. Shaw (2002)
10.1007/BF01992171
Identification ofChlamydia pneumoniae-specific protein antigens in immunoblots
H. Freidank (2005)
IFN-gamma-mediated antimicrobial response. Indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth.
S. Thomas (1993)
10.1084/jem.20022078
Monocytes Heterozygous for the Asp299Gly and Thr399Ile Mutations in the Toll-like Receptor 4 Gene Show No Deficit in Lipopolysaccharide Signalling
C. Erridge (2003)
10.1128/IAI.70.9.5132-5139.2002
A Chlamydia trachomatis-Specific Th2 Clone Does Not Provide Protection against a Genital Infection and Displays Reduced Trafficking to the Infected Genital Mucosa
R. A. Hawkins (2002)
A peptide of Chlamydia trachomatis shown to be a primary T-cell epitope in vitro induces cell-mediated immunity in vivo.
S. Knight (1995)
Identification and distribution of the costimulatory receptor CD28 in the mouse.
J. Gross (1992)
10.1086/315605
Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection.
A. D. Murdin (2000)
10.1128/IAI.66.2.835-838.1998
Inducible Nitric Oxide Synthase Does Not Affect Resolution of Murine Chlamydial Genital Tract Infections or Eradication of Chlamydiae in Primary Murine Cell Culture
K. Ramsey (1998)
10.1186/1471-2334-6-122
Do host genetic traits in the bacterial sensing system play a role in the development of Chlamydia trachomatis-associated tubal pathology in subfertile women?
J. den Hartog (2006)
HPV vaccine MedImmune/GlaxoSmithKline.
A. Billich (2003)
10.1038/ni1160
CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2
X. Tai (2005)
10.1001/JAMA.289.10.1265
Population-based study of chlamydial infection in China: a hidden epidemic.
William L. Parish (2003)
10.1111/J.1365-2605.2006.00718.X
Male serum Chlamydia trachomatis IgA and IgG, but not heat shock protein 60 IgG, correlates with negatively affected semen characteristics and lower pregnancy rates in the infertile couple.
A. Idahl (2007)
10.1073/pnas.162359999
Modulation of TCR-induced transcriptional profiles by ligation of CD28, ICOS, and CTLA-4 receptors
J. Riley (2002)
10.4049/jimmunol.175.11.7536
A Predominant Role for Antibody in Acquired Immunity to Chlamydial Genital Tract Reinfection1
S. Morrison (2005)
10.1046/j.1365-2567.1997.00378.x
B‐cell‐deficient mice develop complete immune protection against genital tract infection with Chlamydia trachomatis
M. Johansson (1997)
10.1046/j.1365-2567.2001.01167.x
Immunological memory in B‐cell‐deficient mice conveys long‐lasting protection against genital tract infection with Chlamydia trachomatis by rapid recruitment of T cells
M. Johansson (2001)
10.1001/JAMA.291.18.2229
Prevalence of chlamydial and gonococcal infections among young adults in the United States.
W. Miller (2004)
10.1086/346044
The role that the functional Asp299Gly polymorphism in the toll-like receptor-4 gene plays in susceptibility to Chlamydia trachomatis-associated tubal infertility.
S. Morré (2003)
10.1128/IAI.68.12.6798-6806.2000
Induction of Protective Immunity against Chlamydia trachomatis Genital Infection by a Vaccine Based on Major Outer Membrane Protein–Lipophilic Immune Response-Stimulating Complexes
J. Igietseme (2000)
10.1007/S10156-004-0332-4
Uncommon occurrence of fluoroquinolone resistance-associated alterations in GyrA and ParC in clinical strains of Chlamydia trachomatis
S. Yokoi (2004)
10.4049/jimmunol.168.3.1302
CD28 Costimulation and Parasite Dose Combine to Influence the Susceptibility of BALB/c Mice to Infection with Leishmania major1
H. L. Compton (2002)
10.4049/jimmunol.166.2.945
IL-18 Enhances IL-4 Production by Ligand-Activated NKT Lymphocytes: A Pro-Th2 Effect of IL-18 Exerted Through NKT Cells1
M. Leite-de-Moraes (2001)
10.1038/35051113
ICOS is essential for effective T-helper-cell responses
A. Tafuri (2001)
10.1099/00222615-47-7-599
Factors influencing the induction of infertility in a mouse model of Chlamydia trachomatis ascending genital tract infection.
S. Pal (1998)
10.1139/m88-028
Characterization of Chlamydia trachomatis antigens with monoclonal and polyclonal antibodies.
I. Maclean (1988)
10.1093/infdis/163.2.233
Cofactors in male-female sexual transmission of human immunodeficiency virus type 1.
F. Plummer (1991)
10.1016/J.VACCINE.2004.04.035
Immune response to the Chlamydia trachomatis outer membrane protein PorB.
D. Kawa (2004)
10.1111/j.1600-0897.2006.00381.x
Effect of Toll‐Like Receptor (TLR) Agonists on TLR and Microbicide Expression in Uterine and Vaginal Tissues of the Mouse
G. Soboll (2006)
10.1046/J.1365-3083.1997.D01-167.X
Studies in knockout mice reveal that anti-chlamydial protection requires TH1 cells producing IFN-gamma: is this true for humans?
M. Johansson (1997)
10.1128/iai.63.2.389-392.1995
Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls.
R. Bailey (1995)
10.1016/S0952-7915(02)00361-8
The role of IFN-γ in the outcome of chlamydial infection
M. Rottenberg (2002)
10.1128/IAI.73.12.8153-8160.2005
Vaccination with the Chlamydia trachomatis Major Outer Membrane Protein Can Elicit an Immune Response as Protective as That Resulting from Inoculation with Live Bacteria
S. Pal (2005)
10.1128/iai.62.9.3705-3711.1994
Tryptophan depletion as a mechanism of gamma interferon-mediated chlamydial persistence.
W. Beatty (1994)
10.1128/iai.63.5.1784-1789.1995
Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis.
T. Cain (1995)
10.4049/jimmunol.164.12.6276
The ADP-Ribosylating CTA1-DD Adjuvant Enhances T Cell-Dependent and Independent Responses by Direct Action on B Cells Involving Anti-Apoptotic Bcl-2- and Germinal Center-Promoting Effects1
L. Ågren (2000)
10.1186/1471-2334-5-105
Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice
J. Lyons (2005)
10.1007/s00345-005-0047-x
Chlamydial infections in urology
F. Wagenlehner (2005)
10.1016/0167-5699(90)90085-N
Role of the CD28 receptor in T-cell activation.
C. June (1990)
10.1128/iai.57.4.1040-1049.1989
Nucleotide and deduced amino acid sequences for the four variable domains of the major outer membrane proteins of the 15 Chlamydia trachomatis serovars.
Y. Yuan (1989)
A Comparison of the Fallopian Tube's Response to Overt and Silent Salpingitis
D. Patton (1989)
10.1007/s004300050076
Clearance of Chlamydia trachomatis– induced polyserositis in SCID mice requires both CD4+ and CD8+ cells
S. Thoma-Uszynski (1998)
10.1073/pnas.241377698
Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes
R. Belland (2001)
10.4049/jimmunol.173.5.3375
A Novel Recombinant Multisubunit Vaccine against Chlamydia1
F. Eko (2004)
10.1016/S0140-6736(01)06886-6
Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection
K. Fenton (2001)
10.1128/JB.187.2.473-479.2005
Interaction between components of the type III secretion system of Chlamydiaceae.
A. Slepenkin (2005)
10.1007/BF02718380
The long term follow-up of asymptomatic women with Chlamydia trachomatis
W. Chaim (2007)
10.1111/j.1574-695X.1996.tb00277.x
Nitric oxide production: a mechanism of Chlamydia trachomatis inhibition in interferon-γ-treated RAW264.7 cells
B. Chen (1996)
10.1016/0163-4453(92)91882-C
Chlamydial vaccines--future trends.
M. E. Ward (1992)
10.1099/00207713-44-3-527
Evolutionary relationships among eubacterial groups as inferred from GroEL (chaperonin) sequence comparisons.
A. Viale (1994)
10.1016/J.VACCINE.2005.07.104
Comparison of intranasal and transcutaneous immunization for induction of protective immunity against Chlamydia muridarum respiratory tract infection.
Kathryn A Skelding (2006)
10.1084/JEM.194.12.1801
Natural Killer T Cell Activation Protects Mice Against Experimental Autoimmune Encephalomyelitis
A. Singh (2001)
Protective cytotoxic T lymphocytes are induced during murine infection with Chlamydia trachomatis.
M. Starnbach (1994)
10.1128/IAI.68.6.3074-3078.2000
Priming with Chlamydia trachomatis Major Outer Membrane Protein (MOMP) DNA followed by MOMP ISCOM Boosting Enhances Protection and Is Associated with Increased Immunoglobulin A and Th1 Cellular Immune Responses
Z. Dong-ji (2000)
10.1128/jb.159.2.713-719.1984
Expression of the gene encoding protein A in Staphylococcus aureus and coagulase-negative staphylococci.
M. Uhlén (1984)
10.1126/science.1373522
Cloning and characterization of inducible nitric oxide synthase from mouse macrophages.
Q. Xie (1992)
10.1093/HUMREP/DEH155
Demonstration of Chlamydia trachomatis IgG antibodies in the male partner of the infertile couple is correlated with a reduced likelihood of achieving pregnancy.
A. Idahl (2004)
10.1071/SH04040
Socio-demographic and behavioural factors associated with high incidence of sexually transmitted infections in female sex workers in Madagascar following presumptive therapy.
F. Behets (2005)
10.1073/pnas.092017799
Truncated hemoglobin HbN protects Mycobacterium bovis from nitric oxide
H. Ouellet (2002)
10.1073/PNAS.97.15.8461
α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria.
G. González-Aseguinolaza (2000)
10.1128/iai.63.9.3302-3308.1995
CD4+ T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract.
H. Su (1995)
Immunol. Cell Biol.
M. Fitzgerald (1995)
10.1093/clinids/7.5.665
Human immune response and Chlamydia trachomatis infection.
D. Kunimoto (1985)
10.1590/S0042-96862004001100009
Global data on visual impairment in the year 2002.
S. Resnikoff (2004)
10.4049/jimmunol.165.9.5035
Mouse Inducible Costimulatory Molecule (ICOS) Expression Is Enhanced by CD28 Costimulation and Regulates Differentiation of CD4+ T Cells1
A. Mcadam (2000)
10.1111/j.1462-5822.2007.00945.x
Lysosome repair enables host cell survival and bacterial persistence following Chlamydia trachomatis infection
W. Beatty (2007)
10.1126/SCIENCE.1084677
Nod1 Detects a Unique Muropeptide from Gram-Negative Bacterial Peptidoglycan
S. Girardin (2003)
Selective loss of the calcium ion signaling pathway in T cells maturing toward a T helper 2 phenotype.
J. Sloan-Lancaster (1997)
10.1128/AAC.43.10.2339
Lack of Cell Wall Peptidoglycan versus Penicillin Sensitivity: New Insights into the Chlamydial Anomaly
J. M. Ghuysen (1999)
10.1093/clinids/23.1.208
Perinatal complications are associated with seropositivity for Chlamydia trachomatis during pregnancy.
K. Numazaki (1996)
10.1099/13500872-140-9-2481
Determination of neutralizing epitopes in variable domains I and IV of the major outer-membrane protein from Chlamydia trachomatis serovar K.
A. Villeneuve (1994)
Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-gamma-dependent and -independent pathways.
L. Perry (1997)
10.1128/iai.65.5.1669-1674.1997
Autoimmunity to heat shock protein 60 and antigen-specific production of interleukin-10.
Y. Yi (1997)
10.1016/J.VACCINE.2005.08.074
Immunization with the Chlamydia trachomatis major outer membrane protein, using adjuvants developed for human vaccines, can induce partial protection in a mouse model against a genital challenge.
S. Pal (2006)
10.1006/bbrc.1997.6462
Induction of NO synthesis by lipoteichoic acid from Staphylococcus aureus in J774 macrophages: involvement of a CD14-dependent pathway.
Y. Hattor (1997)
10.1128/IAI.68.5.2870-2879.2000
In Situ Analysis of the Evolution of the Primary Immune Response in Murine Chlamydia trachomatis Genital Tract Infection
S. Morrison (2000)
10.1016/S0165-0378(98)00009-6
Cytokine induced modulation of MHC class I and class II molecules on human cervical epithelial cells.
G. Ljunggren (1998)
10.1128/iai.61.2.491-497.1993
Gamma interferon-induced nitric oxide production reduces Chlamydia trachomatis infectivity in McCoy cells.
J. Mayer (1993)
10.1086/323341
Chlamydia trachomatis infection induces mucosal addressin cell adhesion molecule-1 and vascular cell adhesion molecule-1, providing an immunologic link between the fallopian tube and other mucosal tissues.
K. Kelly (2001)
Elevated serum Chlamydia trachomatis IgG antibodies. Association with decreased implantation rates in GIFT.
F. Sharara (1999)
10.1128/IAI.71.2.973-984.2003
Restricted Fusion of Chlamydia trachomatis Vesicles with Endocytic Compartments during the Initial Stages of Infection
M. Scidmore (2003)
10.1016/J.VACCINE.2004.04.021
Intranasal immunization with C. muridarum major outer membrane protein (MOMP) and cholera toxin elicits local production of neutralising IgA in the prostate.
D. Hickey (2004)
10.1056/NEJMCP030542
Genital Chlamydial Infections
J. Peipert (2003)
Effect of pelvic inflammatory disease on fertility.
L. Westrom (1995)
10.1128/IAI.69.8.5131-5137.2001
Chlamydia trachomatis Persistence in the Female Mouse Genital Tract: Inducible Nitric Oxide Synthase and Infection Outcome
K. Ramsey (2001)
10.1128/IAI.72.7.3951-3960.2004
Murine Oviduct Epithelial Cell Cytokine Responses to Chlamydia muridarum Infection Include Interleukin-12-p70 Secretion
R. M. Johnson (2004)
10.1097/01.CCM.0000156242.44356.C5
Polymorphisms in CD14, mannose-binding lectin, and Toll-like receptor-2 are associated with increased prevalence of infection in critically ill adults*
A. Sutherland (2005)
10.1016/S0165-2478(97)86163-9
Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit.
L. Ågren (1997)
10.1016/S0264-410X(02)00677-1
Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis.
F. Eko (2003)
10.1074/JBC.M009728200
Human Nod1 Confers Responsiveness to Bacterial Lipopolysaccharides*
N. Inohara (2001)
10.1084/JEM.187.7.1123
Mucosal Adjuvanticity and Immunogenicity of LTR72, a Novel Mutant of Escherichia coli Heat-labile Enterotoxin with Partial Knockout of ADP-ribosyltransferase Activity
M. Giuliani (1998)
10.1046/j.0019-2805.2001.01354.x
Fc receptor regulation of protective immunity against Chlamydia trachomatis
T. Moore (2002)
10.1080/10446670310001598519
CTLA-4 Engagement Inhibits Th2 but not Th1 Cell Polarisation
V. Ubaldi (2003)
10.1128/iai.65.8.3065-3073.1997
Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response.
T. Darville (1997)
10.1128/iai.58.6.2021-2023.1990
Variation in virulence among oculogenital serovars of Chlamydia trachomatis in experimental genital tract infection.
J. Ito (1990)
CD28 costimulation prevents cell death during primary T cell activation.
P. J. Noel (1996)
10.1093/infdis/168.6.1528
Conjunctival scarring in trachoma is associated with depressed cell-mediated immune responses to chlamydial antigens.
M. Holland (1993)
10.1016/0002-9378(80)91077-7
Incidence, prevalence, and trends of acute pelvic inflammatory disease and its consequences in industrialized countries.
L. Weström (1980)
10.1128/iai.65.3.1032-1044.1997
Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response.
M. Johansson (1997)
CD8+ T lymphocyte-mediated lysis of Chlamydia-infected L cells using an endogenous antigen pathway.
P. Beatty (1994)
10.1128/iai.56.5.1320-1325.1988
Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection.
K. Ramsey (1988)
10.1093/HUMREP/DEI269
Experimental Chlamydia trachomatis infection causes apoptosis in human sperm.
A. Satta (2006)
10.1073/PNAS.96.9.5141
Murine natural killer cells contribute to the granulomatous reaction caused by mycobacterial cell walls
I. Apostolou (1999)
10.1097/00000478-199002000-00008
Endometrial Histopathology in Patients with Culture‐proved Upper Genital Tract Infection and Laparoscopically Diagnosed Acute Salpingitis
N. B. Kiviat (1990)
10.1128/IAI.68.11.6398-6401.2000
A Novel Polymorphism in the Toll-Like Receptor 2 Gene and Its Potential Association with Staphylococcal Infection
E. Lorenz (2000)
10.1128/iai.62.11.5195-5197.1994
Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones.
J. Igietseme (1994)
10.1002/(SICI)1521-4141(199911)29:11<3782::AID-IMMU3782>3.0.CO;2-B
IFN-gamma knockout mice show Th2-associated delayed-type hypersensitivity and the inflammatory cells fail to localize and control chlamydial infection.
S. Wang (1999)
10.1128/iai.63.12.4661-4668.1995
Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection.
R. Morrison (1995)
10.1128/IAI.69.8.4996-5000.2001
Immune Response to Chlamydial 60-Kilodalton Heat Shock Protein in Tears from Nepali Trachoma Patients
T. Hessel (2001)
10.1016/J.VACCINE.2006.12.019
Expression library immunization confers partial protection against Chlamydia muridarum genital infection.
C. L. McNeilly (2007)
10.1056/NEJMOA020586
A controlled trial of a human papillomavirus type 16 vaccine.
L. Koutsky (2002)
10.1093/IJE/31.1.194
Risk factors for trachoma in Mali.
J. Schémann (2002)
10.1093/HUMREP/DEI082
Apoptosis of ejaculated human sperm is induced by co-incubation with Chlamydia trachomatis lipopolysaccharide.
A. Eley (2005)
10.4049/jimmunol.171.11.6187
Toll-Like Receptor-2, but Not Toll-Like Receptor-4, Is Essential for Development of Oviduct Pathology in Chlamydial Genital Tract Infection 1
T. Darville (2003)
10.1126/science.7688139
Differential T cell costimulatory requirements in CD28-deficient mice.
A. Shahinian (1993)
10.1128/IAI.72.2.1019-1028.2004
Transcutaneous Immunization with Combined Cholera Toxin and CpG Adjuvant Protects against Chlamydia muridarum Genital Tract Infection
Linda J Berry (2004)
10.1084/jem.20030315
Antigen-dependent Proliferation of CD4+ CD25+ Regulatory T Cells In Vivo
L. Walker (2003)
10.1074/jbc.M610754200
CD1d Degradation in Chlamydia trachomatis-infected Epithelial Cells Is the Result of Both Cellular and Chlamydial Proteasomal Activity*
K. Kawana (2007)
10.1128/IAI.72.12.7164-7171.2004
Human Antibody Responses to a Chlamydia-Secreted Protease Factor
J. Sharma (2004)
10.1126/science.1948068
DNA deaminating ability and genotoxicity of nitric oxide and its progenitors.
D. Wink (1991)
10.1128/IAI.66.11.5202-5207.1998
The Major Outer Membrane Protein of Chlamydia psittaci Functions as a Porin-Like Ion Channel
S. Wyllie (1998)
10.1001/JAMA.285.1.47
Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma.
T. Anttila (2001)
10.1073/PNAS.0504198102
Chlamydial IFN-γ immune evasion is linked to host infection tropism
D. Nelson (2005)
10.1002/PMIC.200400940
Genome and proteome analysis of Chlamydia.
B. B. Vandahl (2004)
10.1046/j.1365-2567.1996.d01-655.x
Molecular mechanism of T‐cell control of Chlamydia in mice: role of nitric oxide in vivo
J. Igietseme (1996)
10.4049/jimmunol.169.1.566
Differential Induction of Mucosal and Systemic Antibody Responses in Women After Nasal, Rectal, or Vaginal Immunization: Influence of the Menstrual Cycle1
P. Kozlowski (2002)
IFN-gamma modulates the early development of Th1 and Th2 responses in a murine model of cutaneous leishmaniasis.
P. Scott (1991)
10.1093/infdis/125.5.471
Response of monkeys to immunization with cholera toxoid, toxin, and vaccine: reversion of cholera toxoid.
R. Northrup (1972)
10.1016/J.VACCINE.2005.08.097
Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
S. Singh (2006)
10.1002/J.1939-4640.2004.TB02764.X
Semen quality of men with asymptomatic chlamydial infection.
Saeid Hosseinzadeh (2004)
10.1016/S0264-410X(02)00631-X
DNA immunization with pgp3 gene of Chlamydia trachomatis inhibits the spread of chlamydial infection from the lower to the upper genital tract in C3H/HeN mice.
M. Donati (2003)
10.1093/embo-reports/kve155
CARD4/Nod1 mediates NF‐κB and JNK activation by invasive Shigella flexneri
S. Girardin (2001)
10.4049/jimmunol.169.10.5813
Inducible Costimulator Protein Controls the Protective T Cell Response Against Listeria monocytogenes1
H. Mittrücker (2002)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar